[Interpretations of guideline for the management of diabetes mellitus in the elderly in China (2021 edition)]

Zhonghua Nei Ke Za Zhi. 2021 Nov 1;60(11):954-959. doi: 10.3760/cma.j.cn112138-20210305-00183.
[Article in Chinese]

Abstract

Elderly diabetic patients in China accounts for one fourth of the total number of elderly diabetic patients in the world, ranking the first worldwide. In 2021, National Center of Gerontology, Chinese Society of Geriatrics and Diabetes Professional Committee of Chinese Aging Well Association issued China's first guideline on elderly diabetic patients--Guideline for the management of diabetes mellitus in the elderly in China (2021 edition). The present article interprets parts of the important recommendations of the guideline, aiming to facilitate its implementation in clinical practice effectively and improve the clinical prognosis of elderly diabetic patients in our country.

我国老年糖尿病患者占全球老年糖尿病患者人数的1/4,居世界首位,但我国一直以来却缺乏针对老年糖尿病的指南以规范老年糖尿病的诊治。2021年国家老年医学中心、中华医学会老年医学分会、中国老年保健协会糖尿病专业委员会组织撰写了我国第一部有关老年糖尿病的指南——《中国老年糖尿病诊疗指南(2021年版)》。本文拟对该指南的部分重要推荐意见进行解读,希望它更有效地指导临床实践,最终改善我国老年糖尿病患者临床预后。.

MeSH terms

  • Aged
  • China
  • Diabetes Mellitus* / diagnosis
  • Diabetes Mellitus* / therapy
  • Humans
  • Prognosis